Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, has announced study results demonstrating that its DecisionDx-Melanoma™ gene expression profile...
At least 30 dogs in England have been killed in less than 18 months by an unknown disease which causes skin lesions and kidney failure, reveals research published in Veterinary Record.
Sebacia, Inc., a company dedicated to delivering breakthrough treatments to advance dermatology, has announced new research showing that selective targeting of sebaceous glands using the Sebacia...
Celgene Corporation has announced that results from its ongoing phase III LIBERATE trial evaluating Otezla® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4)...
Researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found that two common antibiotic treatments work equally well...
Results of a new study by UCLA researchers has found that a new triple combination drug therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK...